Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis)

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 9, 2001, Pages 841-849

  Schmid, P ^a,b   Simon, D ^c   Simon, H U ^d   Akdis, C A ^b   Wuthrich B ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^c Klinik und Poliklinik fur Dermatologie   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Atopic dermatitis; Clinical features; Constitutional dermatitis; Epidemiology; Extrinsic type; Immunopathology; Intrinsic type

Indexed keywords

ALLERGEN; AUTOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; SUPERANTIGEN;

ANTIGEN PRESENTING CELL; ATOPIC DERMATITIS; B LYMPHOCYTE; BASOPHIL; CLINICAL FEATURE; EOSINOPHIL; HEREDITY; HUMAN; IMMUNOLOGY; MAST CELL; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; REVIEW; SKIN BIOPSY; T LYMPHOCYTE;

ASTHMA; CHRONIC DISEASE; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULIN E; PATCH TESTS; PREVALENCE;

EID: 0034869373     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.00144.x     Document Type: Review

References (94)

1. Atopic dermatitis
2. Pathogenesis of atopic dermatitis
3. Environmental and other major provocation factors in atopic dermatitis
4. Atopic dermatitis: From the genes to skin lesions
5. The clinical expression of allergy in the skin
6. The skin as a target for allergic diseases
7. Clinical aspects, epidemiology and prognosis of atopic dermatitis
8. Footnote on the problem of eczema. Neurodermatitis and lichenification
9. Historical notes on atopic dermatitis: Its names and nature
10. IgE and IgG4 levels in children with atopic dermatitis
11. Neurodermitis atopica sive constitutionalis. Ein pathogenetisches modell aus der sicht des allergologen
12. Atopic dermatitis flare provoked by inhalant allergens
13. Immunological aspects of extrinsic and intrinsic asthma
14. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: More similarities than differences
15. What do we know about the etiopathology of the intrinsic type of atopic dermatitis?
16. What is atopy? Condition, disease or a syndrome?
17. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis
18. Diagnostic features of atopic dermatitis
19. Clinical and allergologic-immunologic parameters in patients with atopic dermatitis. A prospective study (1989-1997)
20. Allergic factors associated with the development of asthma and the development and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial first results of ETAC
21. Serum and secretory immunoglobulins in atopic dermatitis
22. Experiences with the severity scoring of atopic dermatitis in a population of German pre-school children
23. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren
24. Contact allergy to aeroallergens in children with atopic dermatitis: Comparison with allergic contact dermatitis
25. Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis
26. Klinische aspekte und allergologisch-immunologische parameter bei 40 kindern von 0-7 jahren mit atopischer dermatitis
27. Atopic dermatitis: Correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity
28. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals
29. Heterogeneity of atopic dermatitis defined by the immune response to inhalant and food allergens
30. Pityrosporum orbiculare - A pathogenic factor in atopic dermatitis of the face, scalp and neck?
31. Atopic dermatitis of the face, scalp, and neck: Type I reaction to the yeast Pityrosporum ovale?
32. Positive atopy patch test reactions to Pityrosporum orbiculare in atopic dermatitis patients
33. Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterization of their cytokine profiles
34. Immune regulation in atopic dermatitis
35. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8 + T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis
36. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis
37. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen
38. 2
39. Induction and regulation of the IgE response
40. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen
41. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis
42. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis
43. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects
44. 4 is a potent in vivo and in vitro eosinophil chemotactic factor in nonallergic asthma
45. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
46. Delayed eosinophil programmed cell death in vitro: A common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis
47. Eosinophils in atopic dermatitis
48. Significant delay of apoptosis and Fas resistance in eosinophils of subjects with intrinsic and extrinsic type of atopic dermatitis
49. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis
50. Enhanced expression of eotaxin and CCR3 in atopic dermatitis
51. Mechanisms of eosinophil-associated inflammation
52. Atopic dermatitis: New insights and opportunities for therapeutic intervention
53. The role of eosinophils and neutrophils in inflammation
54. Allergic inflammation: Skin
55. Mast cells are one major source of interleukin-4 in atopic dermatitis
56. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema
57. Role of Langerhans cells in atopic disease
58. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin
59. Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: A study of the time course of the lesions and with regard to the IgE serum level
60. Fc epsilon RI-expressing antigen-presenting cells: New players in the atopic game
61. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation
62. Phenotyping of epidermal dendritic cells: Clinical applications of a flow cytometric micromethod
63. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: Efficacy, safety, and pharmacokinetics
64. Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis
65. Langerhans cell phenotyping: A new tool for differential diagnosis of inflammatory skin diseases
66. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: Evidence for a novel amplification mechanism in IgE-dependent reactions
67. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody
68. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
69. The atopy patch test: An increased rate of reactivity in patients who have an air-exposed pattern of atopic eczema
70. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis
71. Double-blind controlled trial of effect of house dust-mite allergen avoidance on atopic dermatitis
72. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: A comparison with asthmatic and nonasthmatic control subjects
73. Exposure to indoor allergens in early infancy and sensitization
74. Does sensitization through the skin occur?
75. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample
76. Atopic disease and immunoglobulin E in twins reared apart and together
77. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
78. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children
79. The excess of atopic eczema in East Germany is related to the intrinsic type
80. Hautreaktivität auf menschliche kopfschuppen bei allergischen erkrankungen
81. Der zusammenhang von asthma und ekzem
82. Infantile eczema: Evidence of autoimmunity to human skin
83. Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients
84. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients
85. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions
86. Atopy patch test with different vehicles and allergen concentrations: An approach to standardization
87. Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis
88. The "atopy patch test" in evaluating the role of aeroallergens in atopic eczema
89. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: A randomized, double-blind multicenter study
90. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions
91. Bronchial asthma: Pathophysiology, classic conception and new concepts
92. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma
93. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: Evidence against "intrinsic" asthma being a distinct immunopathologic entity
94. Vergleich atopischer erkrankungen: Beziehung zwischen asthma bronchiale und atopischer dermatitis